Symbols / FLGT Stock $16.29 +2.20% Fulgent Genetics, Inc.

Healthcare • Diagnostics & Research • United States • NGM
FLGT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

Stock Fundamentals
Scroll to Statements
Market Cap 508.75M Enterprise Value 175.43M Income -60.51M Sales 322.67M Book/sh 35.78 Cash/sh 10.76
Dividend Yield — Payout 0.00% Employees 1315 IPO — P/E — Forward P/E -11.14
PEG — P/S 1.58 P/B 0.46 P/C — EV/EBITDA -2.70 EV/Sales 0.54
Quick Ratio 5.03 Current Ratio 6.48 Debt/Eq 0.73 LT Debt/Eq — EPS (ttm) -1.97 EPS next Y -1.46
EPS Growth — Revenue Growth 9.30% Earnings 2026-05-01 ROA -4.58% ROE -5.51% ROIC —
Gross Margin 40.56% Oper. Margin -41.17% Profit Margin -18.75% Shs Outstand 28.84M Shs Float 19.68M Short Float 13.36%
Short Ratio 2.89 Short Interest — 52W High 31.04 52W Low 13.46 Beta 0.89 Avg Volume 545.62K
Volume 442.26K Target Price $26.00 Recom Buy Prev Close $15.94 Price $16.29 Change 2.20%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$26.00
Mean price target
2. Current target
$16.29
Latest analyst target
3. DCF / Fair value
$-75.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$16.29
Low
$22.00
High
$30.00
Mean
$26.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-11 main Piper Sandler Neutral → Neutral $30
2025-08-05 up UBS Neutral → Buy $30
2025-08-04 main Piper Sandler Neutral → Neutral $21
2025-05-06 main Piper Sandler Neutral → Neutral $23
2025-05-05 reit Raymond James Outperform → Outperform $25
2025-03-04 main Piper Sandler Neutral → Neutral $16
2024-11-11 main Piper Sandler Neutral → Neutral $22
2024-03-06 main Piper Sandler Neutral → Neutral $25
2023-12-07 init UBS — → Neutral $35
2023-10-16 main Piper Sandler Neutral → Neutral $28
2023-03-02 main Credit Suisse — → Outperform $45
2022-12-08 down Piper Sandler Overweight → Neutral $40
2022-11-18 init Raymond James — → Outperform $45
2022-11-14 main Credit Suisse — → Outperform $50
2022-11-14 main Piper Sandler — → Overweight $65
2022-08-25 init Credit Suisse — → Outperform $65
2022-05-16 main Piper Sandler — → Overweight $70
2022-01-25 main Oppenheimer — → Outperform $125
2021-08-10 main Credit Suisse — → Underperform $65
2021-03-05 main Piper Sandler — → Overweight $140
News
RSS: Latest FLGT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-24 KIM PAUL Chief Financial Officer — 78,502 $0.00 $0
2026-02-24 GAO HANLIN Officer — 67,120 $0.00 $0
2026-02-24 HSIEH MING Chief Executive Officer — 187,439 $0.00 $0
2026-02-24 XIE JIAN President — 80,464 $0.00 $0
2025-12-02 GAO HANLIN Officer — 1,075 $28.33 $30,457
2025-12-02 XIE JIAN President — 1,140 $28.33 $32,298
2025-11-28 GAO HANLIN Officer — 943 $29.57 $27,884
2025-11-28 XIE JIAN President — 1,198 $29.57 $35,424
2025-11-24 GAO HANLIN Officer — 535 $30.47 $16,303
2025-11-24 XIE JIAN President — 681 $30.47 $20,752
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
322.67
+13.83%
283.47
-1.99%
289.21
-53.27%
618.97
Operating Revenue
322.67
+13.83%
283.47
-1.99%
289.21
-53.27%
618.97
Cost Of Revenue
191.80
+8.82%
176.25
-4.60%
184.76
-26.70%
252.07
Reconciled Cost Of Revenue
175.70
+10.30%
159.29
-4.31%
166.46
-26.31%
225.90
Gross Profit
130.88
+22.07%
107.22
+2.64%
104.46
-71.53%
366.90
Operating Expense
221.97
+22.55%
181.13
+0.77%
179.75
-3.05%
185.40
Research And Development
53.91
+10.42%
48.82
+17.80%
41.44
+43.34%
28.91
Selling General And Administration
160.03
+28.70%
124.35
-4.69%
130.47
-13.02%
149.99
Selling And Marketing Expense
43.37
+19.66%
36.25
-12.59%
41.47
+6.55%
38.92
General And Administrative Expense
116.66
+32.41%
88.11
-1.00%
89.00
-19.87%
111.07
Salaries And Wages
—
—
—
—
Other Gand A
116.66
+32.41%
88.11
-1.00%
89.00
-19.87%
111.07
Total Expenses
413.77
+15.78%
357.39
-1.95%
364.51
-16.68%
437.47
Operating Income
-91.10
-23.24%
-73.92
+1.83%
-75.30
-141.48%
181.50
Total Operating Income As Reported
-91.10
-23.24%
-73.92
+62.20%
-195.53
-209.52%
178.53
EBITDA
-45.83
+6.46%
-48.99
+66.78%
-147.45
-167.73%
217.70
Normalized EBITDA
-35.90
+7.75%
-38.92
-42.97%
-27.22
-112.33%
220.68
Reconciled Depreciation
24.12
-3.23%
24.93
-4.65%
26.14
-19.96%
32.66
EBIT
-69.95
+5.37%
-73.92
+57.42%
-173.60
-193.82%
185.04
Total Unusual Items
-9.93
+1.46%
-10.07
+91.62%
-120.23
-3941.48%
-2.98
Total Unusual Items Excluding Goodwill
-9.93
+1.46%
-10.07
+91.62%
-120.23
-3941.48%
-2.98
Special Income Charges
-9.93
+1.46%
-10.07
+91.62%
-120.23
-3941.48%
-2.98
Impairment Of Capital Assets
0.00
0.00
-100.00%
120.23
0.00
Restructuring And Mergern Acquisition
—
0.00
0.00
-100.00%
2.98
Write Off
9.93
-1.46%
10.07
0.00
0.00
Net Income
-60.51
-41.69%
-42.71
+74.55%
-167.82
-217.03%
143.40
Pretax Income
-70.03
-34.78%
-51.96
+70.15%
-174.09
-194.60%
184.03
Net Non Operating Interest Income Expense
30.84
-2.00%
31.47
+49.00%
21.12
+358.12%
4.61
Interest Expense Non Operating
0.07
—
0.49
-51.83%
1.01
Net Interest Income
30.84
-2.00%
31.47
+49.00%
21.12
+358.12%
4.61
Interest Expense
0.07
—
0.49
-51.83%
1.01
Interest Income Non Operating
30.92
-1.76%
31.47
+45.63%
21.61
+284.28%
5.62
Interest Income
30.92
-1.76%
31.47
+45.63%
21.61
+284.28%
5.62
Other Income Expense
-9.77
-2.74%
-9.51
+92.07%
-119.91
-5643.01%
-2.09
Other Non Operating Income Expenses
0.15
-72.73%
0.56
+75.31%
0.32
-63.92%
0.89
Tax Provision
-8.39
-3.17%
-8.14
-805.03%
1.15
-97.26%
42.10
Tax Rate For Calcs
0.00
-25.57%
0.00
-23.29%
0.00
-7.49%
0.00
Tax Effect Of Unusual Items
-1.19
+26.66%
-1.62
+93.57%
-25.25
-3638.81%
-0.68
Net Income Including Noncontrolling Interests
-61.63
-40.65%
-43.82
+74.99%
-175.24
-223.47%
141.92
Net Income From Continuing Operation Net Minority Interest
-60.51
-41.69%
-42.71
+74.55%
-167.82
-217.03%
143.40
Net Income From Continuing And Discontinued Operation
-60.51
-41.69%
-42.71
+74.55%
-167.82
-217.03%
143.40
Net Income Continuous Operations
-61.63
-40.65%
-43.82
+74.99%
-175.24
-223.47%
141.92
Minority Interests
1.12
+0.54%
1.11
-85.00%
7.41
+400.95%
1.48
Normalized Income
-51.78
-51.14%
-34.26
+52.97%
-72.84
-149.99%
145.70
Net Income Common Stockholders
-60.51
-41.69%
-42.71
+74.55%
-167.82
-217.03%
143.40
Diluted EPS
-1.97
-39.72%
-1.41
+74.96%
-5.63
-221.60%
4.63
Basic EPS
-1.97
-39.72%
-1.41
+74.96%
-5.63
-218.28%
4.76
Basic Average Shares
30.78
+1.79%
30.23
+1.51%
29.78
-1.04%
30.10
Diluted Average Shares
30.78
+1.79%
30.23
+1.51%
29.78
-3.81%
30.96
Diluted NI Availto Com Stockholders
-60.51
-41.69%
-42.71
+74.55%
-167.82
-217.03%
143.40
Amortization
8.03
+0.83%
7.96
+1.53%
7.84
+20.75%
6.50
Amortization Of Intangibles Income Statement
8.03
+0.83%
7.96
+1.53%
7.84
+20.75%
6.50
Depreciation Amortization Depletion Income Statement
8.03
+0.83%
7.96
+1.53%
7.84
+20.75%
6.50
Depreciation And Amortization In Income Statement
8.03
+0.83%
7.96
+1.53%
7.84
+20.75%
6.50
Earnings From Equity Interest Net Of Tax
—
—
0.00
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
1,213.53
-0.53%
1,219.96
-1.24%
1,235.33
Current Assets
550.49
+55.69%
353.57
-30.38%
507.85
Cash Cash Equivalents And Short Term Investments
336.08
+30.21%
258.11
-39.15%
424.15
Cash And Cash Equivalents
50.19
-8.98%
55.14
-43.43%
97.47
Other Short Term Investments
285.88
+40.86%
202.96
-37.87%
326.68
Receivables
91.61
+18.93%
77.03
+34.09%
57.45
Accounts Receivable
84.76
+22.81%
69.02
+34.99%
51.13
Gross Accounts Receivable
106.17
+18.66%
89.48
+17.18%
76.36
Allowance For Doubtful Accounts Receivable
-21.41
-4.66%
-20.46
+18.90%
-25.23
Other Receivables
1.13
-35.86%
1.77
+34.04%
1.32
Accrued Interest Receivable
5.71
-8.44%
6.24
+24.97%
4.99
Inventory
10.60
+26.48%
8.38
+43.88%
5.83
Raw Materials
10.60
+26.48%
8.38
+43.88%
5.83
Prepaid Assets
112.20
+1016.30%
10.05
-50.78%
20.42
Total Non Current Assets
663.03
-23.47%
866.39
+19.09%
727.48
Net PPE
112.55
+6.63%
105.55
+26.46%
83.46
Gross PPE
170.49
+8.42%
157.26
+16.41%
135.10
Accumulated Depreciation
-57.95
-12.06%
-51.71
-0.15%
-51.63
Properties
0.00
0.00
0.00
Land And Improvements
18.29
+0.19%
18.25
+88.08%
9.70
Buildings And Improvements
54.89
+10.63%
49.61
+183.03%
17.53
Machinery Furniture Equipment
26.10
+1.81%
25.63
+0.55%
25.49
Other Properties
66.75
+10.44%
60.44
-15.05%
71.15
Leases
4.47
+34.61%
3.32
-70.39%
11.22
Goodwill And Other Intangible Assets
158.36
+0.85%
157.03
-4.89%
165.11
Goodwill
25.08
+13.72%
22.05
+0.00%
22.05
Other Intangible Assets
133.28
-1.26%
134.98
-5.64%
143.05
Investments And Advances
369.27
-35.26%
570.35
+28.45%
444.01
Other Investments
—
—
—
Other Non Current Assets
22.86
-31.69%
33.46
-4.13%
34.90
Total Liabilities Net Minority Interest
106.81
+17.63%
90.81
-11.01%
102.04
Current Liabilities
84.97
+16.55%
72.90
-0.16%
73.02
Payables And Accrued Expenses
40.79
+30.28%
31.31
-12.75%
35.88
Payables
18.65
+1.58%
18.36
+19.56%
15.36
Accounts Payable
18.65
+1.58%
18.36
+19.56%
15.36
Current Accrued Expenses
22.14
+70.99%
12.95
-36.93%
20.52
Pensionand Other Post Retirement Benefit Plans Current
10.46
+5.75%
9.89
+58.13%
6.25
Total Tax Payable
—
—
—
Income Tax Payable
—
—
—
Current Debt And Capital Lease Obligation
1.94
+4.47%
1.85
-63.91%
5.14
Current Debt
0.48
+15.53%
0.41
-65.17%
1.18
Other Current Borrowings
0.48
+15.53%
0.41
-65.17%
1.18
Current Capital Lease Obligation
1.46
+1.32%
1.44
-63.53%
3.96
Current Deferred Liabilities
31.78
+6.49%
29.84
+16.70%
25.57
Current Deferred Revenue
31.78
+6.49%
29.84
+16.70%
25.57
Other Current Liabilities
—
—
0.16
Total Non Current Liabilities Net Minority Interest
21.84
+21.99%
17.91
-38.31%
29.02
Long Term Debt And Capital Lease Obligation
5.74
-13.22%
6.61
-34.60%
10.11
Long Term Debt
1.96
-21.46%
2.49
-15.89%
2.96
Long Term Capital Lease Obligation
3.78
-8.23%
4.12
-42.35%
7.15
Non Current Deferred Liabilities
6.94
+8.89%
6.37
-19.99%
7.96
Non Current Deferred Taxes Liabilities
6.94
+8.89%
6.37
-19.99%
7.96
Other Non Current Liabilities
9.17
+86.23%
4.92
-55.05%
10.95
Stockholders Equity
1,111.99
-1.87%
1,133.23
-0.25%
1,136.10
Common Stock Equity
1,111.99
-1.87%
1,133.23
-0.25%
1,136.10
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
Share Issued
34.50
+2.64%
33.61
+3.70%
32.42
Ordinary Shares Number
31.08
+0.78%
30.84
+4.01%
29.65
Treasury Shares Number
3.42
+23.33%
2.77
+0.36%
2.76
Additional Paid In Capital
574.52
+5.78%
543.13
+8.25%
501.72
Retained Earnings
529.95
-10.25%
590.47
-6.75%
633.17
Gains Losses Not Affecting Retained Earnings
7.51
+2141.30%
-0.37
-130.54%
1.21
Minority Interest
-5.27
-29.61%
-4.07
-44.55%
-2.81
Other Equity Adjustments
7.51
+2141.30%
-0.37
-130.54%
1.21
Total Equity Gross Minority Interest
1,106.71
-1.99%
1,129.16
-0.36%
1,133.29
Total Capitalization
1,113.95
-1.92%
1,135.72
-0.29%
1,139.07
Working Capital
465.52
+65.86%
280.67
-35.45%
434.83
Invested Capital
1,114.42
-1.91%
1,136.13
-0.36%
1,140.25
Total Debt
7.68
-9.34%
8.47
-44.48%
15.25
Capital Lease Obligations
5.24
-5.75%
5.56
-49.90%
11.10
Net Tangible Assets
953.63
-2.31%
976.20
+0.54%
970.99
Tangible Book Value
953.63
-2.31%
976.20
+0.54%
970.99
Available For Sale Securities
369.27
-35.26%
570.35
+28.45%
444.01
Current Notes Payable
—
—
—
Investmentin Financial Assets
369.27
-35.26%
570.35
+28.45%
444.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-101.64
-582.61%
21.06
-22.01%
27.00
-89.35%
253.52
Cash Flow From Continuing Operating Activities
-101.64
-582.61%
21.06
-22.01%
27.00
-89.35%
253.52
Net Income From Continuing Operations
-61.63
-40.65%
-43.82
+74.99%
-175.24
-223.47%
141.92
Depreciation Amortization Depletion
24.12
-3.23%
24.93
-4.65%
26.14
-19.96%
32.66
Depreciation And Amortization
24.12
-3.23%
24.93
-4.65%
26.14
-19.96%
32.66
Other Non Cash Items
1.79
-52.20%
3.75
-41.28%
6.39
+30.38%
4.90
Stock Based Compensation
39.58
-11.01%
44.48
+3.63%
42.92
+31.50%
32.64
Provisionand Write Offof Assets
7.65
+542.08%
-1.73
-96.59%
-0.88
-102.70%
32.60
Asset Impairment Charge
9.93
-1.46%
10.07
-91.62%
120.23
0.00
Deferred Tax
-0.28
+94.60%
-5.15
-167.69%
7.61
+815.52%
0.83
Deferred Income Tax
-0.28
+94.60%
-5.15
-167.69%
7.61
+815.52%
0.83
Operating Gains Losses
-0.07
-104.95%
1.31
+46.98%
0.89
-25.13%
1.19
Gain Loss On Investment Securities
-0.06
-106.24%
0.99
+68.76%
0.59
-14.88%
0.69
Gain Loss On Sale Of PPE
-0.00
-100.94%
0.32
+4.92%
0.30
-39.24%
0.50
Change In Working Capital
-117.63
-1525.00%
-7.24
-354.80%
2.84
+41.70%
2.00
Change In Receivables
-23.25
-42.62%
-16.30
-782.71%
2.39
-96.52%
68.64
Changes In Account Receivables
-23.25
-42.62%
-16.30
-782.71%
2.39
-96.52%
68.64
Change In Payables And Accrued Expense
9.46
+1157.09%
-0.90
+78.58%
-4.18
+88.48%
-36.25
Change In Accrued Expense
8.91
+324.97%
-3.96
-245.73%
2.72
+124.90%
-10.91
Change In Payable
0.55
-82.06%
3.07
+144.46%
-6.90
+72.79%
-25.34
Change In Account Payable
0.55
-82.06%
3.07
+144.46%
-6.90
+72.79%
-25.34
Change In Other Working Capital
-103.02
-861.34%
13.53
-5.04%
14.25
+140.80%
-34.93
Change In Other Current Assets
0.80
+301.01%
0.20
+105.97%
-3.33
-135.51%
9.38
Change In Other Current Liabilities
-1.62
+56.91%
-3.77
+40.02%
-6.29
-30.14%
-4.83
Investing Cash Flow
111.37
+290.86%
-58.35
-250.01%
38.90
+114.89%
-261.31
Cash Flow From Continuing Investing Activities
111.37
+290.86%
-58.35
-250.01%
38.90
+114.89%
-261.31
Net PPE Purchase And Sale
-22.57
+43.58%
-40.00
-86.65%
-21.43
-16.71%
-18.36
Purchase Of PPE
-22.57
+44.01%
-40.31
-81.54%
-22.21
-18.28%
-18.77
Sale Of PPE
0.01
-98.40%
0.31
-59.61%
0.78
+88.11%
0.41
Capital Expenditure
-22.57
+44.01%
-40.31
-81.54%
-22.21
-18.28%
-18.77
Net Investment Purchase And Sale
130.16
+809.35%
-18.35
-130.22%
60.73
+200.76%
-60.27
Purchase Of Investment
-80.84
+82.89%
-472.42
+3.96%
-491.91
-13.61%
-432.98
Sale Of Investment
211.01
-53.53%
454.06
-17.84%
552.64
+48.28%
372.71
Net Business Purchase And Sale
3.77
0.00
+100.00%
-0.40
+99.78%
-182.68
Purchase Of Business
—
0.00
+100.00%
-0.40
+99.78%
-182.68
Gain Loss On Sale Of Business
—
—
0.00
0.00
Net Intangibles Purchase And Sale
—
—
0.00
0.00
Purchase Of Intangibles
—
—
0.00
0.00
Financing Cash Flow
-14.79
-205.12%
-4.85
+89.86%
-47.78
+38.05%
-77.14
Cash Flow From Continuing Financing Activities
-14.79
-205.12%
-4.85
+89.86%
-47.78
+38.05%
-77.14
Net Issuance Payments Of Debt
-0.87
+50.96%
-1.77
+91.13%
-20.00
-1774.04%
-1.07
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
-0.87
+50.96%
-1.77
+91.13%
-20.00
-1774.04%
-1.07
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
-0.40
+26.65%
-0.54
+25.48%
-0.73
-4.29%
-0.70
Net Long Term Debt Issuance
-0.40
+26.65%
-0.54
+25.48%
-0.73
-4.29%
-0.70
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
-0.47
+61.71%
-1.23
+93.62%
-19.27
-5149.59%
-0.37
Net Short Term Debt Issuance
-0.47
+61.71%
-1.23
+93.62%
-19.27
-5149.59%
-0.37
Net Common Stock Issuance
-13.92
-345.58%
-3.12
+88.76%
-27.79
+63.48%
-76.11
Common Stock Payments
-13.92
-345.58%
-3.12
+88.76%
-27.79
+63.48%
-76.11
Repurchase Of Capital Stock
-13.92
-345.58%
-3.12
+88.76%
-27.79
+63.48%
-76.11
Proceeds From Stock Option Exercised
0.00
-98.04%
0.05
+1600.00%
0.00
-90.32%
0.03
Net Other Financing Charges
—
—
-15.00
-748.42%
-1.77
Changes In Cash
-5.06
+88.00%
-42.14
-332.61%
18.12
+121.33%
-84.94
Effect Of Exchange Rate Changes
0.10
+290.91%
-0.06
+63.09%
-0.15
+67.11%
-0.45
Beginning Cash Position
55.28
-43.29%
97.47
+22.60%
79.51
-51.78%
164.89
End Cash Position
50.33
-8.96%
55.28
-43.29%
97.47
+22.60%
79.51
Free Cash Flow
-124.21
-545.09%
-19.25
-501.48%
4.80
-97.96%
234.75
Interest Paid Supplemental Data
0.05
-89.84%
0.51
-46.67%
0.96
0.00
Income Tax Paid Supplemental Data
96.44
+249.59%
27.59
+746.00%
3.26
-94.20%
56.19
Amortization Of Securities
-5.10
+8.05%
-5.55
-41.91%
-3.91
-182.04%
4.77
Change In Income Tax Payable
—
—
0.00
+100.00%
-0.83
Change In Tax Payable
—
—
0.00
+100.00%
-0.83
Common Stock Issuance
—
—
0.00
0.00
Earnings Losses From Equity Investments
—
—
—
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
Sale Of Business
3.77
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category